Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04024423 · ClinicalTrials.gov registry record
Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic Fibrosis
A clinical trial, sponsored by National Jewish Health.
- Completed
- Registry status
- 100
- Enrollment target
NCT04024423: Completed study, sponsored by National Jewish Health.
NCT04024423 is a clinical trial that has completed, run by National Jewish Health. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04024423 has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Sources of NTM infection and modes of transmission among CF patients are poorly understood. Healthcare-associated transmission of NTM among CF patients has been suspected and is of growing concern for CF Centers. There is a need for a systematic evidence-based approach to investigating potential episodes of healthcare-associated transmission. Clusters of highly similar strains of NTM in CF patients cared for at the same CF Center may arise from healthcare sources including patient-to-patient transmission and/or acquisition from water sources within a healthcare setting. The primary objective of the study is to facilitate a standardized process by which CF Centers may perform data abstraction on patients identified with highly similar NTM isolates and determine if clustered NTM strains are related to strains isolated from healthcare setting water biofilm sources. HALT NTM is available to the entire CF Foundation Care Network, under a collaborative agreement, to initiate a standardized, independent, confidential, internal NTM outbreak investigation. Patients that are identified by whole genome sequencing as having highly similar NTM strains and receiving care in the same CF Care Center are eligible. The study's primary endpoint is to identify potential modes and sources of healthcare-associated acquisition of CF NTM, thereby revealing risk factors for NTM acquisition.
Primary Outcome
Retrospective epidemiologic study
Interventions
- OTHER Epidemiologic investigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2023-07-01 |
What the finished NCT04024423 record still lists
NCT04024423 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Epidemiologic investigation is the first listed.
NCT04024423 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04024423 about?
NCT04024423 is a clinical study titled "Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic Fibrosis". Sources of NTM infection and modes of transmission among CF patients are poorly understood. Healthcare-associated transmission of NTM among CF patients has been suspected and is of growing concern for CF Centers. There is a need for a systematic evidence-based approach to investigating potential epi...
What is the current status of trial NCT04024423?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2019-07-01. Estimated completion is 2023-07-01.
What interventions are being tested in trial NCT04024423?
The interventions under investigation include: Epidemiologic investigation (OTHER).
Who is sponsoring clinical trial NCT04024423?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI